Latest Cancer vaccine Stories
Industry veteran brings nearly 20 years of pharmaceutical development and licensing experience to the company FREDERICK, Md., Jan.
According to the new report from BCC Research, the global market for cancer vaccines is expected to grow to $4.3 billion by 2019, with a five-year compound annual growth rate (CAGR) of 1.3%.
Active Immunotherapy Targets hTERT Gene Associated with 85% of Cancers PLYMOUTH MEETING, Pa., Dec. 18, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.
Dr. Yang led Janssen's prostate cancer and solid tumor therapeutic area in the U.S. PLYMOUTH MEETING, Pa., Dec. 17, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.
LOS ANGELES, Dec. 17, 2014 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd.
SAN DIEGO, Dec. 11, 2014 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc.
DALLAS, December 4, 2014 /PRNewswire/ -- ReportsnReports.com adds The Human Microbiome: Biomedical Implications and Birth of a Market 2014 research report of 94 pages to
A breast cancer vaccine developed at Washington University School of Medicine in St. Louis is safe in patients with metastatic breast cancer, results of an early clinical trial indicate.
-- Plans to Initiate Clinical Studies of Proprietary CAR-T Cell Immunotherapy for Selected Solid Tumors -- SHANGHAI, Nov.
- A morbid dread of being buried alive. Also spelled 'taphiphobia'.